Sufentanil and ANI

• Status: Recruiting
• Trial end date: 2025-01-04
• Target enrollment: 0
• Participant gender: All

Summary

Analgesia Nociception Index (ANI) has been proposed for the evaluation of the nociception-antinociception balance in the perioperative period. In pediatric patients with Moyamoay disease, where the management of analgesia may be rendered difficult by pharmacological changes, we hypothesised that the monitoring of analgesia with ANI would reduce intraoperative opioid consumption during EDAS surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Sufentanil

Criteria

Inclusion Criteria:

• Pediatric patients receiving EDAS surgery for Moyamoya disease

Exclusion Criteria:

• ASA (American society of anesthsiologists classification) 4-5

• Emergency surgery

• patients with chronic pain on medication